AP
Apogee Ther
APGE·NASDAQSan Francisco CAFounded 202260 employees
Mid CapbiotechPublicImmunologyDermatology
Platform: IL-13 Ab
Market Cap
$5B
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (APGE)
Loading APGE stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimainavolisib | APG-3762 | Phase 2 | 2 | C5 | Endometrial Ca | ||
| Rilunesiran | APG-5875 | Phase 1/2 | 2 | GPRC5D | GA | ||
| APG-2066 | APG-2066 | Phase 2 | 1 | TNFα | GBMCTCL |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)